AONN+ Midyear 2022

May 11, 2022 ‐ May 15, 2022



Sessions

AONN+ Behind the Scenes with Your AONN+ Leaders

May 11, 2022 3:00pm ‐ May 11, 2022 4:30pm

Identification: WED01

Speaker(s):
  • Rachael Baranoski, Director, Association Projet Management, Academy of Oncology Nurse & Patient Navigators
  • Monica Dean, HON-OPN-CG, Director of Patient Navigation Program Development, Academy of Oncology Nurse & Patient Navigators
  • Emily Gentry, BSN, RN, HON ONN-CG, OCN, Senior Director of Education and Program Development, Academy of Oncology Nurse & Patient Navigators
  • Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators
  • Lisa Hartman, MS, MA, BSed, BSN, RN, Director of Certification, AONN+ Foundation for Learning
  • Jordan Henderson, Director, Program Development, Academy of Oncology Nurse & Patient Navigators
  • Yamile Leon, MSN, RN, OCN, ONN-CG(T), Supervisor of Patient Navigation, Miami Cancer Institute
  • Erica Williams, BSN, RN, OCN, CBCN, Senior Manager, Certification, Academy of Oncology Nurse & Patient Navigators

Preconference Workshop 1| Understanding the Needs of the LGBTQ Community

May 12, 2022 8:30am ‐ May 12, 2022 11:30am

Identification: THUR01

Speaker(s):
  • Mandi L. Pratt-Chapman, MA, PhD, HON-OPN-CG, Associate Center Director, Patient-Centered Initiatives and Health Equity, GW Cancer Center
  • Natalie Bucklin, MS, Triple Champion Brain Tumor Survivor, The George Washington University
  • Tony Burns, Patient
  • Asa Radix, MD, PhD, MPH, Senior Director of Research and Education, Callen-Lorde Community Health Center

Discussing Anticancer Therapy Along With Patient Monitoring and Management of Adverse Events| Presentation by Merck

May 12, 2022 11:45am ‐ May 12, 2022 1:00pm

Identification: THUR03

Please be sure to login 10-15 minutes early for this session as pre-registration is required. There is not an additional fee to register for this session.


Welcome & Opening Remarks iconWelcome & Opening Remarks

Preview Available

Welcome & Opening Remarks

May 12, 2022 1:00pm ‐ May 12, 2022 1:15pm

Identification: THUR04


General Session 1| Indigenous Oncology Navigation

May 12, 2022 1:15pm ‐ May 12, 2022 2:15pm

Identification: THUR05

Speaker(s):

General Session 2| AYA Tumor Board

May 12, 2022 2:15pm ‐ May 12, 2022 3:15pm

Identification: THUR06

Speaker(s):
  • Paula Sanborn, MS, APRN, FNP-C, CPHON, ONN-CG, Sarcoma Nurse Practitioner, Nationwide Children's Hospital
  • Megan Solinger, MHS, MA, OPN-CG, Director of Patient Navigation at the Ulman Foundation, Ulman Foundation/UMMC

General Session 3| Navigating Global Patients

May 12, 2022 3:15pm ‐ May 12, 2022 4:15pm

Identification: THUR07

Speaker(s):

Enhancing the CLL Patient Experience from Diagnosis to Treatment with Personalized Education in partnership with Pharmacylics

May 12, 2022 4:15pm ‐ May 12, 2022 5:30pm

Identification: THUR08

Speaker(s):
  • Nikki Barkett, BSN, RN, OCN, Oral Antineoplastics Nurse Navigator, Banner University of Arizona Cancer Center
  • Chelsea Passwater, MSN, RN, AGCNS-BC, OCN, Manager, Oncology Navigation, Vidant Health

BOLD: Mentorship Academy “Building Oncology Leadership & Development" and Networking Session

May 12, 2022 5:30pm ‐ May 12, 2022 6:30pm

Identification: THURS09

Speaker(s):
  • Jordan Henderson, Director, Program Development, Academy of Oncology Nurse & Patient Navigators
  • Erica Williams, BSN, RN, OCN, CBCN, Senior Manager, Certification, Academy of Oncology Nurse & Patient Navigators

Importance of Early Detection in Lung Cancer: Elevating the Navigator’s Role| Presentation by AstraZeneca

May 13, 2022 7:45am ‐ May 13, 2022 9:00am

Identification: FRI01

Course participants will discuss the emerging treatment paradigm in lung cancer. Nurse and patient navigators will discuss comprehensive early detection including evolving screening guidelines and biomarker testing within the lung cancer continuum from prevention, diagnosis, treatment, to survivorship. Case examples and best practices will be shared to enrich educational needs of participants.

Learning Objectives:

      • Understand the need for lung cancer screening and pulmonary incidental finding nodule identification
      • Discuss the recent updates in USPSTF Guidelines and CMS Coverage Determination
      • Review the underlying need for biomarker testing and its impact on making an accurate diagnosis
      • Apply learnings to case study examples
      • Enrich the navigator’s practice by the sharing of best practices

Speaker(s):